skip navigation links
National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 14.12e (Release date: 2014-12-29-08:00)
SearchBox Top
SearchBox Bottom
Renal Cell Carcinoma Peptides Vaccine IMA901 (Code C70968)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Renal Cell Carcinoma Peptides Vaccine IMA901

Definition: A multipeptide cancer vaccine targeting renal cell carcinoma with potential immunopotentiating activity. Renal cell carcinoma peptides vaccine IMA901 consists of 10 different synthetic tumor-associated peptide (TUMAP) antigens (9 HLA-class I-binding and 1 HLA class II-binding); endogenously, these TUMAPs are expressed by the majority of renal cell carcinomas. Vaccination with this agent may significantly increase host cytotoxic T-lymphocyte (CTL) immune responses against tumor cells expressing these peptide antigens.

Display Name: Renal Cell Carcinoma Peptides Vaccine IMA901

Label: Renal Cell Carcinoma Peptides Vaccine IMA901

NCI Thesaurus Code: C70968 (Search for linked caDSR metadata)

NCI Metathesaurus CUI: CL375872  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
IMA901
Renal Cell Carcinoma Peptides Vaccine IMA901

External Source Codes: 
NCI META CUI CL375872 (see NCI Metathesaurus info)
PDQ Closed Trial Search ID 570963 (check for NCI PDQ closed clinical trial info)
PDQ Open Trial Search ID 570963 (check for NCI PDQ open clinical trial info)

Other Properties:
code C70968
Contributing_Source CTRP
In_Clinical_Trial_For Renal Cell Carcinoma
Legacy_Concept_Name Renal_Cell_Carcinoma_Peptides_Vaccine_IMA901
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  

URL: http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C70968&ns=NCI_Thesaurus

Mainbox Bottom